IP Library Granted Patent US 10,538,736
Granted Patent B2
US 10,538,736 · App. 15/365,646 · Granted Jan 21, 2020

Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions

Inventors: Gail K. Naughton (Encinitas, CA); Francis C. Zeigler (Encinitas, CA); Mark Baumgartner (San Diego, CA); Kyle Nickey (Vista, CA)
Assignee: Histogen, Inc.
C12N5/0075A61K8/981A61K35/33A61L27/227A61L27/3834A61L27/3895A61Q19/08C07K14/47C12N5/0068C12N5/0627C12N5/0656C12N5/0662A61K38/00C12N2500/02C12N2500/90C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,538,736
App. No.
15/365,646
Granted
Jan 21, 2020
Kind
B2
Abstract

The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Claims (10)

1. A method of producing a composition for improvement of a tissue in a subject comprising:

culturing fibroblast cells under hypoxic conditions on microcarrier beads or a three dimensional surface in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the growth medium a composition that promotes repair and regeneration of damaged tissue when administered to the region of tissue in need of repair in the subject, and

collecting the growth medium after the 2 weeks,

thereby producing the composition.

2. The method of claim 1 , wherein the subject has erythema, edema and/or crusting.

3. The method of claim 1 , wherein the cells are cultured on microcarrier beads.

4. The method of claim 1 , wherein the composition comprises a soluble fraction.

5. The method of claim 1 , wherein the composition comprises a non-soluble fraction.

6. The method of claim 1 , wherein the composition comprises a soluble and a non-soluble fraction.

7. The method of claim 1 , wherein the tissue is skin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2024
From: HISTOGEN INC.
To: ALLERGAN SALES, LLC
Reel/Frame 067559/0977 →
Continuity (9)
Continuation 14011672 · Aug 27, 2013
Continuation 12547422 · Aug 25, 2009
Continuation In Part 12509171 · Jul 24, 2009
Continuation In Part 12501312 · Jul 10, 2009
Continuation In Part 12363488 · Jan 30, 2009
Provisional Application 61050940 · May 6, 2008
Provisional Application 61034361 · Mar 6, 2008
Provisional Application 61024854 · Jan 30, 2008
Related Publication 20170145380A1 · May 25, 2017